Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A8HN
|
||||
Former ID |
DNCL002483
|
||||
Drug Name |
Iboctadekin
|
||||
Indication | Non-hodgkin's lymphoma; Ovarian cancer [ICD9: 183; ICD10:C85, C56] | Phase 1 | [546479] | ||
Company |
GlaxoSmithKline
|
||||
Target and Pathway | |||||
Target(s) | Interleukin-18 | Target Info | Modulator | [550351] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
PANTHER Pathway | Interleukin signaling pathway | ||||
Toll receptor signaling pathway | |||||
Reactome | Interleukin-1 processing | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.